Gray area for new heart failure drug

Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.

A "new" drug called BiDil (it's actually two old ones) is the first medication approved for a particular racial group, in this case blacks with moderate-to-severe heart failure. The interesting thing is, it may work just as well for members of other racial or ethnic groups with this all-too-common condition.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »